Sign in

Sarah Aitken

@s-j-aitken.bsky.social
1.6K followers 1.5K following 123 posts

Clinician Scientist & Pathologist Assistant Professor, Yale School of Medicine • posts≠employer www.aitkenlab.org #GenomicPathology

PostsRepliesMedia
Reposted by Sarah Aitken
Marta Grońska-Pęski @gronskapeski.bsky.social · 09/09/2026
Can dietary interventions change how fast genomes accumulate mutations with age? We studied how caloric restriction (CR)—one of the most robust lifespan-extending interventions—affects somatic mutations across the genome in different tissues and cell types in mice.
11311
Sarah Aitken @s-j-aitken.bsky.social · 08/09/2026
It’s less than two weeks until Closer To Free Ride 2026! Registration is still open to join us on the road for 10, 25, 40, 65, or 100 miles Or if you prefer your feet on solid ground, we need a few extra volunteers; opportunities here: www.rideclosertofree.org/volunteer #CTFRide #hoperideswithus
rideclosertofree.org
Closer to Free Ride
The Closer to Free Ride supports patient care and research at Smilow Cancer Hospital and Yale Cancer Center. Learn more today at www.rideclosertofree.org.
110
Reposted by Sarah Aitken
Inigo Martincorena @imartincorena.bsky.social · 03/09/2026
Big paper alert! This project has been years in the making. A comprehensive description of somatic mutation rates and signatures across 53 tissues or cell types using NanoSeq. A large collective effort led by Mimy Pham, Mike Stratton and @r-rahbari.bsky.social. www.biorxiv.org/content/10.6...
biorxiv.org
A comprehensive atlas of somatic mutation rates and mutational signatures in normal human cells
Over the course of a lifetime, somatic mutations accrue in normal human cells, causing variation in cell phenotype and engendering somatic evolution with outcomes ranging from the adaptive immune syst...
05027
Sarah Aitken @s-j-aitken.bsky.social · 03/09/2026
Great work from Dr Claudia Arnedo-Pac, with friends and colleagues from the Histopathology and Genomics Core Facilities at CRUK Cambridge Institute @cruk-ci.bsky.social Spatial Single Cell RNA Profiling of Human Liver FFPE Tissue Microarrays Using Xenium In Situ link.springer.com/protocol/10....
link.springer.com
Spatial Single Cell RNA Profiling of Human Liver FFPE Tissue Microarrays Using Xenium In Situ
Spatially resolved transcriptomics was named Method of the Year 2020 and has continued to evolve rapidly since then, providing novel insights in development, physiology, and disease processes. Many ap...
020
Reposted by Sarah Aitken
Tom Sasani @tomsasani.bsky.social · 02/09/2026
How long does DNA damage last? @aaronquinlan.bsky.social and I found evidence that lesions are transmitted from parent (P0) to offspring (F1) in C. elegans. If they segregate unrepaired for multiple cell divisions, lesions generate multi-allelism in the F1 germline. www.biorxiv.org/content/10.6...
biorxiv.org
Inherited DNA damage generates multi-allelic mutations in C. elegans
Exogenous and endogenous mutagens generate a wide variety of DNA lesions, including bulky adducts, chemical modifications, and single- or double-stranded breaks. A phenomenon called “lesion segregation,” in which lesions evade repair and persist for multiple cell divisions, has recently been documented in tumors and healthy somatic tissues from mice and humans, respectively. Persistent lesions can generate multi-allelic variants (MAVs) by serving as templates for multiple rounds of error-prone replication. By reanalyzing data from a large C. elegans mutagenesis experiment, we observed robust evidence for MAVs at a small fraction (∼0.2%) of mutated sites in the offspring of strains treated with alkylating agents. Because these sequencing data were derived from the progeny of a single F1 animal — itself the offspring of a mutagenized P0 — all mutations should be biallelic. The presence of multi-allelic variation implies that some DNA lesions are transmitted to the F1 zygote, evade repair, and are repeatedly bypassed by error-prone polymerases during embryogenesis. We suspect that many more lesions are inherited than is suggested by MAV prevalence, and that a large fraction of biallelic mutations are also caused by inherited lesions. Our results demonstrate that DNA lesions serve as durable, transgenerational templates for mutagenesis in C. elegans . We speculate that lesion segregation in the early embryo may be a source of mosaicism and genetic diversity in humans, as well. ### Competing Interest Statement The authors have declared no competing interest. National Institutes of Health, https://ror.org/01cwqze88, R01HG012252
14424
Reposted by Sarah Aitken
Martin Taylor @mstaylor.bsky.social · 30/08/2026
Engines of genetic diversity... Transgenerational lesion segregation in worms, very nice work by Aaron Quinlan @aaronquinlan.bsky.social & Thomas Sasani
242
Sarah Aitken @s-j-aitken.bsky.social · 02/09/2026
Today was our fifth lab-iversary! This year we celebrated... 1 successful PhD viva 2 new preprints 3 relocated TC hoods 4 new team members 5 YEARS OF THE LAB Thank you to everyone who made these things possible 🤩
290
Reposted by Sarah Aitken
Barbara Hernando @bhernando.bsky.social · 10/08/2026
Check it now! 💫 Exited to share this preprint, the result of a fantastic collaboration between Sarah Aitken’s and Martin Taylor’s labs. During my secondment at @yalecancer.bsky.social @yalepathology.bsky.social, I contributed to explore how H&E images can be used to predict tumour genomics
043
Sarah Aitken @s-j-aitken.bsky.social · 10/08/2026
🔬NEW PREPRINT🔬 Explainable machine learning relates histological to genomic pathology www.biorxiv.org/content/10.6... From John Connelly and Barbara Hernando @bhernando.bsky.social, co-led with Martin Taylor @mstaylor.bsky.social - along with others from #LCEConsortium #genomicPathology #ml #ai
1103
Reposted by Sarah Aitken
Cancer Research UK Cambridge Institute @cruk-ci.bsky.social · 27/07/2026
New research from an international collaboration with roots in the CI suggests why DNA damage from smoking, UV rays and other factors may cause cancer in some people but not others. Find out more: www.cruk.cam.ac.uk/news/study-r...
022
Reposted by Sarah Aitken
Colin Semple @csemple.bsky.social · 28/07/2026
Monumental new paper from a great collaboration full of exceptional humans! www.nature.com/articles/s41...
nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...
154
Reposted by Sarah Aitken
Yale Cancer Center @yalecancer.bsky.social · 27/07/2026
A new study published in @nature.com by @s-j-aitken.bsky.social shows how an individual's inherited genetic background shapes cancer risk, how tumors evolve, and how aggressively they progress + could lead to more personalized cancer prevention and treatment. medicine.yale.edu/cancer/publi...
medicine.yale.edu
Genetic Background Shapes Cancer Evolution and Tumor Progression
This study investigates how genetic background affects cancer evolution, showing that inherited genetic differences shape tumor growth, driver mutations, and
042
Reposted by Sarah Aitken
Yale School of Medicine @yaleschoolofmed.bsky.social · 27/07/2026
In a new @nature.com study, YSM researchers examine how inherited #genetics influence the progression and evolution of #liver #cancer. Learn more and find the full study: medicine.yale.edu/publication-...
051
Reposted by Sarah Aitken
Nature @nature.com · 27/07/2026
Nature research paper: Genetic background sets the trajectory of experimental cancer evolution go.nature.com/3RzmnjJ
go.nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stages of cancer development.
0239
Reposted by Sarah Aitken
Paul Flicek @paulflicek.bsky.social · 27/07/2026
It's fantastic to see this finally published! Huge credit to @s-j-aitken.bsky.social and @mstaylor.bsky.social for their determination and creativity on this project, which went in many unexpected directions (with many people along for the ride) and way beyond the initial experimental questions
092
Reposted by Sarah Aitken
Institute of Genetics and Cancer @uoe-igc.bsky.social · 27/07/2026
Great to see the publication of this paper in @nature.com involving @mstaylor.bsky.social as part of an international team of researchers.
131
Reposted by Sarah Aitken
Martin Taylor @mstaylor.bsky.social · 27/07/2026
To what extent is cancer development deterministic? Does the germline genome affect that predictability? We re-ran cancer evolution to answer these questions. www.nature.com/articles/s41...
Phylogenetic tree of four mouse strains illustrating how clonal expansions differ between them following a DNA damaging exposure. Stylistic replay symbol illustrating the re-running of cancer evolution.
1145
Reposted by Sarah Aitken
Martin Taylor @mstaylor.bsky.social · 27/07/2026
Thread from @s-j-aitken.bsky.social explaining our new paper that finds strong epistatic interactions between germline genetic background and somatic driver mutations that set the course of cancer development.
0116
Sarah Aitken @s-j-aitken.bsky.social · 27/07/2026
🧬NEW PAPER🧬 To what extent is cancer development deterministic? Does the germline genome affect that predictability? Find out in our #StrainDifferences paper @nature.com "Genetic background sets the trajectory of experimental cancer evolution" www.nature.com/articles/s41... 🧵[1/14]
nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...
14717
Reposted by Sarah Aitken
Barbara Marte @barbmarte.bsky.social · 22/07/2026
new out in Nature www.nature.com/articles/s41...
nature.com
Genetic background sets the trajectory of experimental cancer evolution - Nature
Experimentally replaying tumour evolution in divergent mouse strains reveals the importance of interactions between genetic ancestry and acquired cancer-driving mutations in shaping the earliest stage...
02514
Sarah Aitken @s-j-aitken.bsky.social · 17/06/2026
I’m very grateful to be one of the 2026 Pew-Stewart Cancer Research scholars! Thanks to @pew.org and The Alexander and Margaret Stewart Trust for supporting, @yalecancer.bsky.social for nominating, and my lab, mentors, collaborators, letter writers, and reviewers for their confidence in our work.
6122
Reposted by Sarah Aitken
Yale Cancer Center @yalecancer.bsky.social · 16/06/2026
Congratulations to Sarah Aitken, MBChB, PhD, @s-j-aitken.bsky.social, named to the 2026 class of the Pew-Stewart Scholars Program for Cancer Research. medicine.yale.edu/news-article... @pewtrusts.bsky.social @yalepathology.bsky.social
062
Sarah Aitken @s-j-aitken.bsky.social · 26/05/2026
Two great postdoc projects, amazing team, fabulous city… ⬇️
020
Sarah Aitken @s-j-aitken.bsky.social · 29/04/2026
Congratulations to Dr Klaske Schukken for her postdoc work on aneuploidy dependencies: three different approaches, dozens of genome wide CRISPR screens, and functionally validated results. Well done Klaske 🤩
140
Reposted by Sarah Aitken
Nuria Lopez-Bigas @nlbigas.bsky.social · 15/04/2026
Tumor promotion through the lens of evolution This review grew out of many long conversations, shared ideas, and lively discussions It has been a real pleasure to think together with Allan, Paul, Eve, and Abel about how tumours develop and how carcinogens shape cancer risk rdcu.be/fdC2J
rdcu.be
Tumour promotion through the lens of evolution
Nature - This Review revisits tumour initiation and promotion in light of clonal diversity and the presence of cancer driver mutations in normal tissues, aiming to understand mechanisms that enable...
13314
Reposted by Sarah Aitken
Inigo Martincorena @imartincorena.bsky.social · 15/04/2026
Excited to share our latest work in Nature. Applying single-molecule and single-cell DNA sequencing methods, we uncover an extraordinary landscape of somatic mutations in immune checkpoint genes in autoimmune B cells, suggesting that somatic mutations may be key to autoimmunity [1/n] rdcu.be/fdqbr
rdcu.be
Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity
Nature - Polyclonal selection of immune checkpoint mutations in thyroid autoimmunity
14720
Sarah Aitken @s-j-aitken.bsky.social · 09/03/2026
The 67th #IWD of 2026 👩🏽‍💻👩🏼‍🔬👩🏾‍⚕️👩🏻‍🏫🌈✊🏾🌍
020
Reposted by Sarah Aitken
Institute of Genetics and Cancer @uoe-igc.bsky.social · 04/03/2026
We’re excited to reveal that team CAUSE led by Ludmil Alexandrov at @ucsandiego.bsky.social has been selected by @cancergrand.bsky.social to receive up to $25m over approx 5 years to take on one of cancer’s toughest challenges. Congratulations @mstaylor.bsky.social from IGC & team: edin.ac/4kYC1iR
2114
Reposted by Sarah Aitken
Cancer Grand Challenges @cancergrand.bsky.social · 04/03/2026
📰 News announcement! www.cancergrandchallenges.org/new-teams-an... We’re thrilled to welcome five world-leading scientific teams, each awarded up to £20 million, to take on some of the toughest unanswered questions in #CancerResearch. Find out more about the teams and their challenges.
cancergrandchallenges.org
$125m awarded to five visionary teams
$125m awarded to five visionary teams
1198
Sarah Aitken @s-j-aitken.bsky.social · 11/02/2026
Today (and every day), we are doing our bit towards Building Inclusive Futures for Women and Girls (and men and boys) Claudia, Emma, and Yi in Cambridge; Barbara in Madrid; and Klaske, Rohini, Tanuja, Vanessa, and Katie in New Haven 👩🏻‍💻👩🏼‍🔬👩🏽‍⚕️ #idwgs2026 #WomenInSTEM #WWCode
170
Reposted by Sarah Aitken
Rohini Janivara @rohinijanivara.bsky.social · 09/02/2026
Thank you @s-j-aitken.bsky.social for the warm welcome! So pumped to join the team and study tiny tweaks reshaping (evolutionary) history 🧬⚡️🦀
031
Sarah Aitken @s-j-aitken.bsky.social · 09/02/2026
🥳 Welcome to Dr Rohini Janivara @rohinijanivara.bsky.social who has joined the #AitkenLab @yaleschoolofmed.bsky.social as a postdoctoral associate. Rohini completed her PhD in bioinformatics at Georgia Tech - and now we are looking forward to working together on all things mutations and cancer!
160
Sarah Aitken @s-j-aitken.bsky.social · 22/01/2026
Very grateful to have received the Wyllie Medal from the Pathological Society of Great Britain & Ireland and to share our collaborative work on "Genomic Pathology: from DNA mutations to cancer evolution" #GenomicPathology #EvolutionAndDisease #PathSoc #JeanShanks
3120
Reposted by Sarah Aitken
Barbara Hernando @bhernando.bsky.social · 19/12/2025
Thanks for everything! I will miss being around in the lab but see you online 🫶🏻
021
Sarah Aitken @s-j-aitken.bsky.social · 19/12/2025
It has been an absolute pleasure to host @bhernando.bsky.social here at @yalecancer.bsky.social for the last few months! I've learnt so much, and your generosity and enthusiasm will be greatly missed. Looking forward to future collaboration, friendship - and paella 🤩 @yalepathology.bsky.social
0100
Sarah Aitken @s-j-aitken.bsky.social · 04/12/2025
Celebrating my first year at @yaleschoolofmed.bsky.social with two talks today: @yalepathology.bsky.social Grand Rounds at lunchtime. And the Center of GI Cancers seminar this evening - thanks to @pamelakunzmd.bsky.social for the invite!
0110
Reposted by Sarah Aitken
Barbara Hernando @bhernando.bsky.social · 28/11/2025
📢 New preprint out! We are thrilled to introduce our framework to track #ongoingCIN by leveraging single-cell genomics and CIN signatures: www.biorxiv.org/content/10.1...
biorxiv.org
Tracking ongoing chromosomal instability using single-cell whole-genome sequencing
Chromosomal instability (CIN) generates aneuploid genomes that are characteristic of most cancers. While bulk genome sequencing reveals historical CIN, it lacks the resolution to identify ongoing CIN ...
2164
Reposted by Sarah Aitken
Martin Taylor @mstaylor.bsky.social · 04/11/2025
The exciting next instalment of Mutations in Time and Space... Open for registration now
077
Reposted by Sarah Aitken
EVOMG-Doctoral Network @evomg-dn.bsky.social · 07/10/2025
📢 EvoMG-DN PhD applications are now open! Join our EU-funded MSCA network and explore evolution, ageing, and disease. 👉 www.evomg-dn.eu 📅 Apply by 30 November 2025 #PhD #DoctoralTraining #MSCA #HorizonEurope #Genomics #EvolutionaryBiology #BiomedicalResearch#EarlyCareerResearchers
0813
Reposted by Sarah Aitken
Barbara Hernando @bhernando.bsky.social · 30/10/2025
It was an honor to take part in the @yalepathology.bsky.social research retreat today! Great science, inspiring discussions, a fun “guess who?”, and wonderful people. Huge thanks to organizers for such a great work! Can’t believe only 2 months left to enjoy this amazing #AitkenLab team ✨
011
Sarah Aitken @s-j-aitken.bsky.social · 30/10/2025
Today was our first Yale Pathology Department retreat - with Klaske, Barbara, Jacob, and Vanessa (we missed you Tanuja!) Great to present our work with a poster and two talks, share ideas, and meet new people 🇨🇦🇪🇸🇬🇧🇳🇱🇺🇸🌎 @yalepathology.bsky.social @bhernando.bsky.social
1101
Sarah Aitken @s-j-aitken.bsky.social · 26/10/2025
Find out all about what's going on in Dr Coraline Mlynarczyk‬'s lab - our neighbours at #CMCO... 📽️ Exploring the interface between Immunology and Cancer @yalepathology.bsky.social
030
Sarah Aitken @s-j-aitken.bsky.social · 10/10/2025
A trio of talks this week: Grand Rounds @jhu.edu yesterday. Then @bhernando.bsky.social (who has only been here a fortnight!) and I gave talks at the NYC Genome Integrity Discussion group @rockefeller.edu. Thanks for inviting us Agata Smogorzewska and Philipp Oberdoerffer @yalepathology.bsky.social
092
Reposted by Sarah Aitken
Nuria Lopez-Bigas @nlbigas.bsky.social · 08/10/2025
🚨 New paper alert! Sex and smoking bias in the selection of somatic mutations in human bladder www.nature.com/articles/s41... by @raquelbmi.bsky.social, @ferriol.bsky.social et al (in collaboration with Rosana Risques lab in @uwmedicine.bsky.social)
nature.com
Sex and smoking bias in the selection of somatic mutations in human bladder - Nature
Sex bias and association with smoking history identified in the landscape of driver mutations and clonal expansions in normal human bladder tissue may explain the higher bladder cancer risk in men and smokers.
27029
Reposted by Sarah Aitken
Barbara Hernando @bhernando.bsky.social · 29/09/2025
Exciting 3 months ahead at the #AitkenLab @yaleschoolofmed.bsky.social! 🤩 Huge thanks to @s-j-aitken.bsky.social for the warm welcome, and to @caixaresearch.bsky.social for supporting my research career at all levels ✨
051
Sarah Aitken @s-j-aitken.bsky.social · 29/09/2025
🥳 Today we welcome Dr Bárbara Hernando @bhernando.bsky.social to the #AitkenLab @yaleschoolofmed.bsky.social Bárbara joins us from #CNIO as part of her @caixaresearch.bsky.social Postdoctoral Junior Leader Fellowship @yalepathology.bsky.social @yalecancer.bsky.social @cniostopcancer.bsky.social
051
Sarah Aitken @s-j-aitken.bsky.social · 07/09/2025
A fantastic (first) Closer to Free Ride: 100 miles with friends from #NHBC, colleagues from @yalecancer.bsky.social , and a #CycloPath we met along the way. Thank you for all the sponsorship - and the support on the road! #CTFRide @ctfride.bsky.social
050
Sarah Aitken @s-j-aitken.bsky.social · 03/09/2025
Yesterday was our fourth lab-iversary 🥳 In the last year we moved to the US, welcomed new lab members at Yale and in Cambridge, mastered Transatlantic hybrid lab life, posted preprints, published others, submitted grants... Looking forward to what year five has in store! @yalepathology.bsky.social
1161
Reposted by Sarah Aitken
Muzumdar Lab @muzumdarlab.bsky.social · 26/08/2025
💡 Cancer cells don’t just mutate—they reorganize their DNA in 3D space. Our new study shows how the genome’s folding pattern shifts as tumors progress, cell by cell 🧩🧬. It’s the first 3D genome atlas of cancer progression. Thread 👇
1114
Sarah Aitken @s-j-aitken.bsky.social · 22/08/2025
Almost half way to our fundraising target - and only two weeks to go! I'll be riding the 100 mile #CloserToFreeRide to raise money to support cancer research and patient care. Please consider donating - every penny counts! ➡️ www.rideclosertofree.org/participants... #CTFRide @ctfride.bsky.social
rideclosertofree.org
A fundraising page for Sarah Aitken
Join the Closer to Free Ride on Saturday, September 6th. Register or donate at RideCloserToFree.org.
011